Reshma Shringarpure
Company: Akero
Job title: Vice President
Seminars:
Panel Discussion | Translating GLP-1s, Rezmiteron, FGF21 Therapies into Clinical Practice Guidelines in a Rapidly Changing Landscape 3:30 pm
Assessing how current therapies fit into the standard of care Navigating the future of combination therapies to optimize treatment Evaluating how this will play out in the real world with access, non-responders, standard of care and the shift to primary care providersRead more
day: Conf Day 1 EOD
Spotlighting Clinical Data Supporting Anti-Fibrotic Mechanisms of EFX 2:15 pm
Detailing direct and indirect antifibrotic activity of EFX shown clinically Improving insulin sensitivity and restoring lipoprotein profile to restore metabolic health and achieve sustained responses Dissecting the implications of these findings on long term clinical outcomesRead more
day: Conf Day 2 PM